ScholarLens Back to search
2008•Jilin yixueRequires access

Sequential levofloxacin administration in the treatment of community acquired pneumonia

LI Yi-dong

Open publisher page 0 citations

Abstract

Objective To survey the safety and clinical therapeutic effectiveness of sequential levofloxacin administration in the treatment of community acquired pneumonia(CAP).Method 56 cases of CAP were randomly divided into 2 equal groups:levofloxcin alone and ceftriaxone plus azithromycin,and the efficacy,the eradication rates of pathogens and the rates of side effects were observed.Results The overall effective rates,in levofloxacin group and ceftriaxone plus azithromycin group were 92.8% and 89.2%,respectively(P 0.05),the eradication rates of pathogens were 88.2% and 87.5%,respectively(P0.05),the rates of side effects were 3.57% amd 3.57 %,respectively(P 0.05),and there was no siynificant difference between two groups.Conclusion The sequential levofloxacin medication is safe,effective and handy in the treatment of patients with community acquired pneumonia.

About this research paper

What this paper is about

Objective To survey the safety and clinical therapeutic effectiveness of sequential levofloxacin administration in the treatment of community acquired pneumonia(CAP).Method 56 cases of CAP were randomly divided into 2 equal groups:levofloxcin alone and ceftriaxone plus azithromycin,and the efficacy,the eradication rates of pathogens and the rates of side effects were observed.Results The overall effective rates,in levofloxacin group and ceftriaxone plus azithromycin group were 92.8% and 89.2%,respectively(P 0.05),the eradication rates of pathogens were 88.2% and 87.5%,respectively(P0.05),the rates of side effects were 3.57% amd 3.57 %,respectively(P 0.05),and there was no siynificant difference between two groups.Conclusion The sequential levofloxacin medication is safe,effective and handy in the treatment of patients with community acquired pneumonia.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To survey the safety and clinical therapeutic effectiveness of sequential levofloxacin administration in the treatment of community acquired pneumonia(CAP).Method 56 cases of CAP were randomly divided into 2 equal groups:levofloxcin alone and ceftriaxone plus azithromycin,and the efficacy,the eradication rates of pathogens and the rates of side effects were observed.Results The overall effective rates,in levofloxacin group and ceftriaxone plus azithromycin group were 92.8% and 89.2%,respectively(P 0.05),the eradication rates of pathogens were 88.2% and 87.5%,respectively(P0.05),the rates of side effects were 3.57% amd 3.57 %,respectively(P 0.05),and there was no siynificant difference between two groups.Conclusion The sequential levofloxacin medication is safe,effective and handy in the treatment of patients with community acquired pneumonia.

Key concepts: Medicine, Levofloxacin, Azithromycin, Ceftriaxone, Community-acquired pneumonia, Pneumonia, Internal medicine, Antibiotics

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Sequential levofloxacin administration in the treatment of community acquired pneumonia — Research Paper | ScholarLens